Factor | Juntunen2010 (10010)

10.1016/j.vetmic.2010.04.027

Tylosin use

Swine | Weaners

7

Description

Tylosin was administered in feed (body weight dose of 3–6 mg/kg/day) to treat proliferative enteropathy. Measurement of treated pigs was 3-5 weeks after withdrawl of tylosin.

Resistance Outcomes

Resistance Microbe Outcome
Ampicillin
/
Campylobacter coli
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Tylosin use 0 15
No use 0 57
Ciprofloxacin
/
Campylobacter coli
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Tylosin use 3 15
No use 2 57
Erythromycin
/
Campylobacter coli
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Tylosin use 4 15
No use 0 57
Gentamicin
/
Campylobacter coli
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Tylosin use 0 15
No use 0 57
Nalidixic Acid
/
Campylobacter coli
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Tylosin use 3 15
No use 2 57
Streptomycin
/
Campylobacter coli
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Tylosin use 1 15
No use 0 57
Tetracycline
/
Campylobacter coli
See: Table 2 AMR+ (n) AMR- (n) Total (n)
Tylosin use 0 15
No use 0 57